Thyrotropin serum levels and coexistence with Hashimoto's thyroiditis as predictors of malignancy in children with thyroid nodules.
Childhood
Nodular lymphocytic thyroiditis
Pre-cancerous factors
Subclinical hypothyroidism
TSH serum levels
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
06 Aug 2019
06 Aug 2019
Historique:
received:
28
03
2019
accepted:
30
07
2019
entrez:
8
8
2019
pubmed:
8
8
2019
medline:
31
1
2020
Statut:
epublish
Résumé
Thyroid cancer (TC) in childhood is a rare disease characterized by an excellent prognosis. Thyroid nodules in children, although less common than in adults, have a greater risk of malignancies, particularly in those cases associated with anamnestic, clinical and ultrasonographic risk factors.Among the factors, which have been found to be linked with an increased relative risk of TC in children, an important role seems to be possibly played by an underlying nodular Hashimoto's thyroiditis (HT) and by the serum levels of TSH.Aim of this Commentary was to specifically address this last point.According to the available pediatric literature on the relationships between these risk factors and phenotypical expression of TC in children, it is possible to conclude that: 1) It is not completely clarified if HT per se predisposes to malignancy or if it represents an incidental histologic finding in cases with TC or if it may be the result of an immune response against tumoral cells. 2) It is unclear whether phenotypic expression of TC is more severe in the cases with associated HT but normal TSH serum levels. 3) Persistently elevated TSH levels play an independent role as predictors of the likelihood of TC, especially in children but also in adults. 4) Patients with nodular HT and subclinical hypothyroidism need to be treated with Levothyroxine in order to prevent the development of both TC and severe thyroid dysfunctions.
Identifiants
pubmed: 31387613
doi: 10.1186/s13052-019-0693-z
pii: 10.1186/s13052-019-0693-z
pmc: PMC6685280
doi:
Substances chimiques
Biomarkers, Tumor
0
Thyrotropin
9002-71-5
Types de publication
Letter
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
96Références
Radiology. 2005 Dec;237(3):794-800
pubmed: 16304103
Nat Clin Pract Endocrinol Metab. 2007 May;3(5):422-9
pubmed: 17452969
Hormones (Athens). 2007 Jul-Sep;6(3):194-9
pubmed: 17724003
Hormones (Athens). 2007 Jul-Sep;6(3):200-9
pubmed: 17724004
Arch Pediatr Adolesc Med. 2008 Jun;162(6):526-31
pubmed: 18524742
Endocr Relat Cancer. 2011 Jul 01;18(4):429-37
pubmed: 21565972
Endocr Rev. 2011 Dec;32(6):798-826
pubmed: 21880704
Horm Res Paediatr. 2012;77(1):36-40
pubmed: 22286076
J Clin Endocrinol Metab. 2012 Aug;97(8):2682-92
pubmed: 22622023
Clin Endocrinol (Oxf). 2013 Mar;78(3):472-7
pubmed: 22924613
J Endocrinol Invest. 2013 May;36(5):313-20
pubmed: 22931861
Horm Res Paediatr. 2012;78(4):232-6
pubmed: 23128840
Eur J Endocrinol. 2013 Feb 15;168(3):343-9
pubmed: 23211578
J Clin Endocrinol Metab. 2013 Feb;98(2):474-82
pubmed: 23293329
Ital J Pediatr. 2013 Jan 30;39:8
pubmed: 23363471
J Clin Endocrinol Metab. 2013 Aug;98(8):3238-45
pubmed: 23737541
J Pediatr. 2013 Nov;163(5):1465-70
pubmed: 23972643
J Endocrinol Invest. 2014 Mar;37(3):303-8
pubmed: 24474680
J Pediatr Endocrinol Metab. 2014 Sep;27(9-10):901-8
pubmed: 24854523
J Pediatr Endocrinol Metab. 2015 Jul;28(7-8):793-5
pubmed: 25153565
Thyroid. 2015 Feb;25(2):176-82
pubmed: 25340407
Thyroid. 2015 Jul;25(7):716-59
pubmed: 25900731
J Pediatr. 2015 Oct;167(4):886-892.e1
pubmed: 26164379
Eur J Endocrinol. 2015 Dec;173(6):827-33
pubmed: 26369577
Eur J Endocrinol. 2015 Dec;173(6):801-8
pubmed: 26374873
Thyroid. 2016 Oct;26(10):1450-1456
pubmed: 27541075
Eur Thyroid J. 2017 Jul;6(4):178-186
pubmed: 28868258
Ital J Pediatr. 2018 Jan 17;44(1):13
pubmed: 29343289
J Endocr Soc. 2019 Jan 04;3(3):607-616
pubmed: 30820486
Front Endocrinol (Lausanne). 2019 Feb 25;10:109
pubmed: 30858827